Search

everythinglearnresearchcommunity

for

Search:↓

PRP treatment may help improve hair density and thickness in breast cancer patients with therapy-induced hair loss.

Finasteride harms Daphnia magna's reproduction, growth, and metabolism.

Finasteride harms Daphnia magna's reproduction and metabolism.

Endocrine therapy helps with reproductive and metabolic issues in women with PCOS.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Endocrine disruptors may cause early hair loss.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Hair melanocytes help the skin respond to stress and regulate hair pigmentation.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

Removing Sprouty genes in mice causes various hormone-related issues but does not increase cancer risk by one year of age.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

Doctors should check for serious tumor causes of high androgen levels in postmenopausal women and more research is needed on this condition.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

New hormonal therapies can help treat advanced prostate cancer but may cause testicular issues.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Effective hirsutism treatment for women with PCOS should be personalized and may include lifestyle changes and medication.

Hormonal imbalances, often indicating conditions like PCOS, are common in women with hard-to-treat acne, and a treatment approach addressing these imbalances may be needed.

Primary amenorrhea and delayed puberty in females can be diagnosed and managed effectively.

Hair growth and health are influenced by stress and hormones.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Hormones significantly influence hair growth, with conditions like hirsutism and patterned hair loss linked to hormone levels; more research is needed for full understanding.

Dermatologists can help diagnose endocrine disorders like PCOS and metabolic syndrome by looking at skin symptoms.

Skin symptoms can indicate endocrine disorders and have various treatments.

Skin problems can be a sign of hormone-related diseases.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.